LLY - ELI LILLY & Co
1007.73
-10.240 -1.016%
Share volume: 2,836,879
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$1,017.97
-10.24
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 04-30-2024 | 08-08-2024 | 10-30-2024 | 02-19-2025 | 05-01-2025 | 08-07-2025 | 10-30-2025 | 02-12-2026 | |
| Assets | |||||||||
| Total Assets | 63.944 B | 71.875 B | 75.607 B | 78.715 B | 89.389 B | 100.923 B | 114.935 B | 112.476 B | |
| Current Assets | 25.189 B | 30.204 B | 31.415 B | 32.740 B | 41.261 B | 49.854 B | 62.071 B | 55.629 B | |
| Inventories | 6.102 B | 6.482 B | 7.460 B | 7.589 B | 9.311 B | 11.014 B | 12.180 B | 13.744 B | |
| Other Current Assets | 138.600 M | 142.200 M | 134.600 M | 111.400 M | 72.400 M | 68.800 M | 271.500 M | 147.000 M | |
| Short Term Investments | 126.100 M | 140.400 M | 149.400 M | 154.800 M | 127.400 M | 170.100 M | 121.600 M | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 2.460 B | 3.224 B | 3.369 B | 3.268 B | 3.093 B | 3.376 B | 9.792 B | 7.268 B | |
| Total Non-current Assets | 3.087 B | 2.878 B | 3.200 B | 3.216 B | 3.223 B | 3.207 B | 2.808 B | 2.802 B | |
| Property Plant Equipment | 13.624 B | 14.829 B | 16.172 B | 17.102 B | 18.474 B | 20.530 B | 22.316 B | 24.675 B | |
| Other Assets | 25.131 B | 26.841 B | 28.020 B | 28.873 B | 29.654 B | 30.539 B | 30.548 B | 32.172 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 63.944 B | 71.875 B | 75.607 B | 78.715 B | 89.389 B | 100.923 B | 114.935 B | 112.476 B | |
| Total liabilities | 51.046 B | 58.239 B | 61.286 B | 64.443 B | 73.542 B | 82.574 B | 91.085 B | 85.941 B | |
| Total current liabilities | 18.598 B | 27.121 B | 24.674 B | 28.377 B | 30.068 B | 39.020 B | 40.141 B | 35.228 B | |
| Accounts Payable | 2.474 B | 2.925 B | 2.887 B | 3.229 B | 3.442 B | 4.076 B | 4.262 B | 5.379 B | |
| Other liabilities | 2.271 B | 2.471 B | 2.239 B | 2.178 B | 2.288 B | 2.345 B | 3.777 B | 3.970 B | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 24.560 B | 23.730 B | 29.045 B | 28.527 B | 34.500 B | 34.180 B | 40.874 B | 40.868 B | |
| Other liabilities | 2.271 B | 2.471 B | 2.239 B | 2.178 B | 2.288 B | 2.345 B | 3.777 B | 3.970 B | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 12.812 B | 13.562 B | 14.240 B | 14.192 B | 15.765 B | 18.273 B | 23.793 B | 26.513 B | |
| Common stock | 7.604 B | 7.808 B | 7.934 B | 8.032 B | 7.503 B | 7.681 B | 7.823 B | 7.936 B | |
| Retained earnings | 12.554 B | 13.178 B | 13.627 B | 13.545 B | 15.100 B | 17.376 B | 22.252 B | 24.470 B |